Eli Lilly to supply 400,000 tablets of its COVID-19 treatment to India


  • World
  • Tuesday, 04 May 2021

FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo

(Reuters) -Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to the Indian government as the country fights a raging pandemic that has morgues and hospitals overflowing.

With 3.45 million active cases, India recorded 357,229 new infections over the last 24 hours, while deaths rose 3,449 for a toll of 222,408, health ministry data showed. Experts say actual numbers could be five to 10 times higher, however.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

India foreign minister says vandalism of Hindu temples in Australia deeply concerning
'Panic buttons', SWAT teams: US braces for election unrest
US states worried about election unrest take security precautions
US arrests Turk for allegedly trying to break Venezuela sanctions
Brazil's Haddad presents fiscal proposals to Lula, but no measures announced
U.S. stocks close lower before election
Georgia top court won't extend ballot deadline in win for Trump
285 migrants intercepted off Libyan coast in past week: IOM
Algeria projects 4.5 pct economic growth in 2025: minister
Mexico Congress likely to pass reform abolishing autonomous bodies by mid-November, official says

Others Also Read